These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 1832417)
1. Combined activity of trospectomycin and colloidal bismuth subcitrate against Helicobacter pylori in vitro. Vogt K; Rodloff AC; Hahn H Infection; 1991; 19(3):138-9. PubMed ID: 1832417 [TBL] [Abstract][Full Text] [Related]
2. Synergism between clindamycin and colloidal bismuth subcitrate against Helicobacter (Campylobacter) pylori in vitro. Vogt K; Hahn H Zentralbl Bakteriol; 1990 Nov; 274(2):246-9. PubMed ID: 2085373 [TBL] [Abstract][Full Text] [Related]
3. Potentiation of the action of metronidazole on Helicobacter pylori by omeprazole and bismuth subcitrate. Andersen LP; Colding H; Kristiansen JE Int J Antimicrob Agents; 2000 Apr; 14(3):231-4. PubMed ID: 10773493 [TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of Helicobacter pylori to trospectomycin, pirlimycin (U-57930E), mirincamycin (U-24729A) and N-demethyl clindamycin (U-26767A). Westblom TU; Midkiff BR; Czinn SJ Eur J Clin Microbiol Infect Dis; 1993 Jul; 12(7):560-2. PubMed ID: 8404921 [TBL] [Abstract][Full Text] [Related]
5. Solubility, absorption, and anti-Helicobacter pylori activity of bismuth subnitrate and colloidal bismuth subcitrate: In vitro data Do not predict In vivo efficacy. Phillips RH; Whitehead MW; Lacey S; Champion M; Thompson RP; Powell JJ Helicobacter; 2000 Sep; 5(3):176-82. PubMed ID: 10971684 [TBL] [Abstract][Full Text] [Related]
6. Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents. Debets-Ossenkopp YJ; Namavar F; MacLaren DM Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):353-5. PubMed ID: 7649202 [TBL] [Abstract][Full Text] [Related]
7. Colloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics. Marcus EA; Sachs G; Scott DR Aliment Pharmacol Ther; 2015 Oct; 42(7):922-33. PubMed ID: 26238858 [TBL] [Abstract][Full Text] [Related]
8. [In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin]. González C; García A; Daroch F; Kawaguchi F; Solar H; Rivera N; Vega E Rev Med Chil; 2001 Jun; 129(6):643-6. PubMed ID: 11510204 [TBL] [Abstract][Full Text] [Related]
9. Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori. Brenciaglia MI; Fornara AM; Scaltrito MM; Braga PC; Dubini F J Chemother; 1996 Feb; 8(1):52-4. PubMed ID: 8835109 [TBL] [Abstract][Full Text] [Related]
10. The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori. Vogt K; Warrelmann M; Hahn H Zentralbl Bakteriol; 1989 Sep; 271(3):304-10. PubMed ID: 2803458 [TBL] [Abstract][Full Text] [Related]
11. In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori). Van Caekenberghe DL; Breyssens J Antimicrob Agents Chemother; 1987 Sep; 31(9):1429-30. PubMed ID: 3674850 [TBL] [Abstract][Full Text] [Related]
12. The action of bismuth against Helicobacter pylori mimics but is not caused by intracellular iron deprivation. Bland MV; Ismail S; Heinemann JA; Keenan JI Antimicrob Agents Chemother; 2004 Jun; 48(6):1983-8. PubMed ID: 15155188 [TBL] [Abstract][Full Text] [Related]